Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

HongYan Xu

Showing results (391-400 of 394) with videos related to

Pageof 40
Sort By:
You have reached the last page of results.This site can display upto 394 results.
Ebiomedicine|July 26, 2020
An effective vaginal gel to deliver CRISPR/Cas9 system encapsulated in poly (β-amino ester) nanoparticles for vaginal gene therapyGang Niu, Zhuang Jin, Chong Zhang, et al.
Therapeutic Advances in Medical Oncology|November 4, 2022
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancerMin Yan, Peng Yuan, Quchang Ouyang, et al.
Infection|April 3, 2024
Efficacy and safety of oral ibrexafungerp in Chinese patients with vulvovaginal candidiasis: a phase III, randomized, double-blind studyXiaoqian Wang, Wenying Wang, Jingjing Li, et al.
Nature Medicine|January 22, 2025
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trialLin Shen, Yanqiao Zhang, Ziyu Li, et al.
Pageof 40

Showing results (391-400 of 394) with videos related to

Sort By:
Pageof 40
You have reached the last page of results.This site can display upto 394 results.
Ebiomedicine|July 26, 2020
An effective vaginal gel to deliver CRISPR/Cas9 system encapsulated in poly (β-amino ester) nanoparticles for vaginal gene therapyGang Niu, Zhuang Jin, Chong Zhang, et al.
Therapeutic Advances in Medical Oncology|November 4, 2022
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancerMin Yan, Peng Yuan, Quchang Ouyang, et al.
Infection|April 3, 2024
Efficacy and safety of oral ibrexafungerp in Chinese patients with vulvovaginal candidiasis: a phase III, randomized, double-blind studyXiaoqian Wang, Wenying Wang, Jingjing Li, et al.
Nature Medicine|January 22, 2025
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trialLin Shen, Yanqiao Zhang, Ziyu Li, et al.
Pageof 40